ERICA FOX: Open Payments
NPI 1043850357 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,184 in 82 payments from 16 companies in 2025. Trend: 2023 $1,737 · 2024 $1,920 · 2025 $3,184
Food & beverage: $1,826Travel & lodging: $1,357
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 17 | $1,926 |
| Merck Sharp & Dohme LLC | 10 | $191 |
| Actelion Pharmaceuticals US, Inc. | 7 | $152 |
| PFIZER INC. | 10 | $141 |
| Penumbra, Inc. | 1 | $135 |
| E.R. Squibb & Sons, L.L.C. | 6 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $72 |
| Novartis Pharmaceuticals Corporation | 4 | $72 |
Products named: ELIQUIS, OPSUMIT, VERQUVO, Indigo System, JARDIANCE, Kerendia, LifeVest, LEQVIO.
Industry payments across LA — which companies pay providers there.
